NEOGENOMICS INC (NEO)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$727.3M$660.6M$591.6M$509.7M$484.3M$444.4M$408.8M$276.7M$240.3M$231.8M
Gross profit$314.3M$290.1M$244.6M$187.9M$187.1M$185.9M$196.8M$127.3M$102.0M$98.1M$43.8M$40.7M$31.7M$26.8M$19.4M$15.8M
Research & development$37.1M$31.2M$27.3M$30.3M$21.9M$8.2M$8.5M$3.0M$3.6M$4.6M$4.2M$2.7M$2.4M$2.3M$543,000
Operating expenses$430.2M$382.2M$352.3M$345.5M$305.8M$199.9M$183.8M$117.2M$99.1M$95.9M$49.4M$38.5M$28.6M$25.6M$19.8M$18.7M
Operating income−$115.9M−$92.1M−$107.7M−$157.6M−$118.8M−$14.0M$13.0M$10.0M$2.9M$2.2M−$5.6M$2.2M$3.2M$1.2M−$409,000−$3.0M
EBITDAderived−$48.1M−$19.6M−$35.2M−$88.2M−$65.4M$11.9M$33.4M$25.8M$18.5M$18.1M$1.1M$7.6M$7.4M$4.8M
Net income−$108.0M−$78.7M−$88.0M−$144.3M−$8.3M$4.2M$8.0M$2.6M−$396,000−$6.1M−$2.5M$1.1M$2.0M$65,000−$1.2M−$3.3M
Basic EPSper diluted share-$0.04$0.02$0.04$0.00-$0.03-$0.09
Diluted EPSper diluted share-$0.04$0.02$0.04$0.00-$0.03-$0.09

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys10$797.7K disclosed value
Sells (SEC code S)7$791.8K disclosed value
17 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 15, 2026Form 4 · 10b5-1TETRAULT LYNN A.DirectorSellCommon Stock5.3K$11.10$58.9K86.1K
Jun 9, 2026Form 4 · 10b5-1TETRAULT LYNN A.DirectorSellCommon Stock5.3K$11.29$59.9K91.4K
Jan 20, 2026Form 4 · 10b5-1Stone WarrenPres & Chief Operating OfficerSellCommon Stock22.1K$12.50$276.6K121.6K
Nov 25, 2025Form 4 · 10b5-1Olivo Alicia CEVP, GC & Business DevelopmentSellCommon Stock20.9K$12.00$251.0K31.1K
Oct 16, 2025Form 4 · 10b5-1Olivo Alicia CEVP, GC & Business DevelopmentSellCommon Stock4.9K$10.00$49.2K43.0K